Global Biological API Drug Manufacturing Market Insights, Forecast to 2029

TABLE OF CONTENTS

1 Study Coverage

• 1.1 Biological API Drug Manufacturing Product Introduction
• 1.2 Market by Type
  • 1.2.1 Global Biological API Drug Manufacturing Market Size by Type, 2018 VS 2022 VS 2029
  • 1.2.2 In-House manufacturing
  • 1.2.3 Contract manufacturing
• 1.3 Market by Application
  • 1.3.1 Global Biological API Drug Manufacturing Market Size by Application, 2018 VS 2022 VS 2029
  • 1.3.2 Monoclonal Antibody (mAb) Therapies
  • 1.3.3 Vaccines
  • 1.3.4 Insulin Therapies
  • 1.3.5 Interferon Therapies
  • 1.3.6 Other
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Global Biological API Drug Manufacturing Production

• 2.1 Global Biological API Drug Manufacturing Production Capacity (2018-2029)
• 2.2 Global Biological API Drug Manufacturing Production by Region: 2018 VS 2022 VS 2029
• 2.3 Global Biological API Drug Manufacturing Production by Region
  • 2.3.1 Global Biological API Drug Manufacturing Historic Production by Region (2018-2023)
  • 2.3.2 Global Biological API Drug Manufacturing Forecasted Production by Region (2024-2029)
  • 2.3.3 Global Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
• 2.4 North America
• 2.5 Europe
• 2.6 China
• 2.7 Japan

3 Executive Summary

• 3.1 Global Biological API Drug Manufacturing Revenue Estimates and Forecasts 2018-2029
• 3.2 Global Biological API Drug Manufacturing Revenue by Region
  • 3.2.1 Global Biological API Drug Manufacturing Revenue by Region: 2018 VS 2022 VS 2029
  • 3.2.2 Global Biological API Drug Manufacturing Revenue by Region (2018-2023)
  • 3.2.3 Global Biological API Drug Manufacturing Revenue by Region (2024-2029)
  • 3.2.4 Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2029)
• 3.3 Global Biological API Drug Manufacturing Sales Estimates and Forecasts 2018-2029
• 3.4 Global Biological API Drug Manufacturing Sales by Region
  • 3.4.1 Global Biological API Drug Manufacturing Sales by Region: 2018 VS 2022 VS 2029
  • 3.4.2 Global Biological API Drug Manufacturing Sales by Region (2018-2023)
  • 3.4.3 Global Biological API Drug Manufacturing Sales by Region (2024-2029)
  • 3.4.4 Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2029)
• 3.5 US & Canada
• 3.6 Europe
• 3.7 China
• 3.8 Asia (excluding China)
• 3.9 Middle East, Africa and Latin America

4 Competition by Manufactures

• 4.1 Global Biological API Drug Manufacturing Sales by Manufacturers
  • 4.1.1 Global Biological API Drug Manufacturing Sales by Manufacturers (2018-2023)
  • 4.1.2 Global Biological API Drug Manufacturing Sales Market Share by Manufacturers (2018-2023)
  • 4.1.3 Global Top 10 and Top 5 Largest Manufacturers of Biological API Drug Manufacturing in 2022
• 4.2 Global Biological API Drug Manufacturing Revenue by Manufacturers
  • 4.2.1 Global Biological API Drug Manufacturing Revenue by Manufacturers (2018-2023)
  • 4.2.2 Global Biological API Drug Manufacturing Revenue Market Share by Manufacturers (2018-2023)
  • 4.2.3 Global Top 10 and Top 5 Companies by Biological API Drug Manufacturing Revenue in 2022
• 4.3 Global Biological API Drug Manufacturing Sales Price by Manufacturers
• 4.4 Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2021 VS 2022 VS 2023
• 4.5 Analysis of Competitive Landscape
  • 4.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
  • 4.5.2 Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
• 4.6 Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters
• 4.7 Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application
• 4.8 Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry
• 4.9 Mergers & Acquisitions, Expansion Plans

5 Market Size by Type

• 5.1 Global Biological API Drug Manufacturing Sales by Type
  • 5.1.1 Global Biological API Drug Manufacturing Historical Sales by Type (2018-2023)
  • 5.1.2 Global Biological API Drug Manufacturing Forecasted Sales by Type (2024-2029)
  • 5.1.3 Global Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• 5.2 Global Biological API Drug Manufacturing Revenue by Type
  • 5.2.1 Global Biological API Drug Manufacturing Historical Revenue by Type (2018-2023)
  • 5.2.2 Global Biological API Drug Manufacturing Forecasted Revenue by Type (2024-2029)
  • 5.2.3 Global Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• 5.3 Global Biological API Drug Manufacturing Price by Type
  • 5.3.1 Global Biological API Drug Manufacturing Price by Type (2018-2023)
  • 5.3.2 Global Biological API Drug Manufacturing Price Forecast by Type (2024-2029)

6 Market Size by Application

• 6.1 Global Biological API Drug Manufacturing Sales by Application
  • 6.1.1 Global Biological API Drug Manufacturing Historical Sales by Application (2018-2023)
  • 6.1.2 Global Biological API Drug Manufacturing Forecasted Sales by Application (2024-2029)
  • 6.1.3 Global Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• 6.2 Global Biological API Drug Manufacturing Revenue by Application
  • 6.2.1 Global Biological API Drug Manufacturing Historical Revenue by Application (2018-2023)
  • 6.2.2 Global Biological API Drug Manufacturing Forecasted Revenue by Application (2024-2029)
  • 6.2.3 Global Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• 6.3 Global Biological API Drug Manufacturing Price by Application
  • 6.3.1 Global Biological API Drug Manufacturing Price by Application (2018-2023)
  • 6.3.2 Global Biological API Drug Manufacturing Price Forecast by Application (2024-2029)

7 US & Canada

• 7.1 US & Canada Biological API Drug Manufacturing Market Size by Type
  • 7.1.1 US & Canada Biological API Drug Manufacturing Sales by Type (2018-2029)
  • 7.1.2 US & Canada Biological API Drug Manufacturing Revenue by Type (2018-2029)
• 7.2 US & Canada Biological API Drug Manufacturing Market Size by Application
  • 7.2.1 US & Canada Biological API Drug Manufacturing Sales by Application (2018-2029)
  • 7.2.2 US & Canada Biological API Drug Manufacturing Revenue by Application (2018-2029)
• 7.3 US & Canada Biological API Drug Manufacturing Sales by Country
  • 7.3.1 US & Canada Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
  • 7.3.2 US & Canada Biological API Drug Manufacturing Sales by Country (2018-2029)
  • 7.3.3 US & Canada Biological API Drug Manufacturing Revenue by Country (2018-2029)
  • 7.3.4 U.S.
  • 7.3.5 Canada

8 Europe

• 8.1 Europe Biological API Drug Manufacturing Market Size by Type
  • 8.1.1 Europe Biological API Drug Manufacturing Sales by Type (2018-2029)
  • 8.1.2 Europe Biological API Drug Manufacturing Revenue by Type (2018-2029)
• 8.2 Europe Biological API Drug Manufacturing Market Size by Application
  • 8.2.1 Europe Biological API Drug Manufacturing Sales by Application (2018-2029)
  • 8.2.2 Europe Biological API Drug Manufacturing Revenue by Application (2018-2029)
• 8.3 Europe Biological API Drug Manufacturing Sales by Country
  • 8.3.1 Europe Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
  • 8.3.2 Europe Biological API Drug Manufacturing Sales by Country (2018-2029)
  • 8.3.3 Europe Biological API Drug Manufacturing Revenue by Country (2018-2029)
  • 8.3.4 Germany
  • 8.3.5 France
  • 8.3.6 U.K.
  • 8.3.7 Italy
  • 8.3.8 Russia

9 China

• 9.1 China Biological API Drug Manufacturing Market Size by Type
  • 9.1.1 China Biological API Drug Manufacturing Sales by Type (2018-2029)
  • 9.1.2 China Biological API Drug Manufacturing Revenue by Type (2018-2029)
• 9.2 China Biological API Drug Manufacturing Market Size by Application
  • 9.2.1 China Biological API Drug Manufacturing Sales by Application (2018-2029)
  • 9.2.2 China Biological API Drug Manufacturing Revenue by Application (2018-2029)

10 Asia (excluding China)

• 10.1 Asia Biological API Drug Manufacturing Market Size by Type
  • 10.1.1 Asia Biological API Drug Manufacturing Sales by Type (2018-2029)
  • 10.1.2 Asia Biological API Drug Manufacturing Revenue by Type (2018-2029)
• 10.2 Asia Biological API Drug Manufacturing Market Size by Application
  • 10.2.1 Asia Biological API Drug Manufacturing Sales by Application (2018-2029)
  • 10.2.2 Asia Biological API Drug Manufacturing Revenue by Application (2018-2029)
• 10.3 Asia Biological API Drug Manufacturing Sales by Region
  • 10.3.1 Asia Biological API Drug Manufacturing Revenue by Region: 2018 VS 2022 VS 2029
  • 10.3.2 Asia Biological API Drug Manufacturing Revenue by Region (2018-2029)
  • 10.3.3 Asia Biological API Drug Manufacturing Sales by Region (2018-2029)
  • 10.3.4 Japan
  • 10.3.5 South Korea
  • 10.3.6 China Taiwan
  • 10.3.7 Southeast Asia
  • 10.3.8 India

11 Middle East, Africa and Latin America

• 11.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Market Size by Type
  • 11.1.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2018-2029)
  • 11.1.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2018-2029)
• 11.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Market Size by Application
  • 11.2.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2018-2029)
  • 11.2.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2018-2029)
• 11.3 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country
  • 11.3.1 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country: 2018 VS 2022 VS 2029
  • 11.3.2 Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2018-2029)
  • 11.3.3 Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2018-2029)
  • 11.3.4 Brazil
  • 11.3.5 Mexico
  • 11.3.6 Turkey
  • 11.3.7 Israel
  • 11.3.8 GCC Countries

12 Corporate Profiles

• 12.1 Lonza
  • 12.1.1 Lonza Company Information
  • 12.1.2 Lonza Overview
  • 12.1.3 Lonza Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.1.4 Lonza Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.1.5 Lonza Recent Developments
• 12.2 Boehringer Ingelheim BioXcellence
  • 12.2.1 Boehringer Ingelheim BioXcellence Company Information
  • 12.2.2 Boehringer Ingelheim BioXcellence Overview
  • 12.2.3 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.2.4 Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.2.5 Boehringer Ingelheim BioXcellence Recent Developments
• 12.3 Celltrion
  • 12.3.1 Celltrion Company Information
  • 12.3.2 Celltrion Overview
  • 12.3.3 Celltrion Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.3.4 Celltrion Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.3.5 Celltrion Recent Developments
• 12.4 DSM
  • 12.4.1 DSM Company Information
  • 12.4.2 DSM Overview
  • 12.4.3 DSM Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.4.4 DSM Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.4.5 DSM Recent Developments
• 12.5 Samsung BioLogics
  • 12.5.1 Samsung BioLogics Company Information
  • 12.5.2 Samsung BioLogics Overview
  • 12.5.3 Samsung BioLogics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.5.4 Samsung BioLogics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.5.5 Samsung BioLogics Recent Developments
• 12.6 Fujifilm Diosynth Biotechnologies
  • 12.6.1 Fujifilm Diosynth Biotechnologies Company Information
  • 12.6.2 Fujifilm Diosynth Biotechnologies Overview
  • 12.6.3 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.6.4 Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.6.5 Fujifilm Diosynth Biotechnologies Recent Developments
• 12.7 Cytovance Biologics
  • 12.7.1 Cytovance Biologics Company Information
  • 12.7.2 Cytovance Biologics Overview
  • 12.7.3 Cytovance Biologics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.7.4 Cytovance Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.7.5 Cytovance Biologics Recent Developments
• 12.8 AbbVie
  • 12.8.1 AbbVie Company Information
  • 12.8.2 AbbVie Overview
  • 12.8.3 AbbVie Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.8.4 AbbVie Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.8.5 AbbVie Recent Developments
• 12.9 Baxter
  • 12.9.1 Baxter Company Information
  • 12.9.2 Baxter Overview
  • 12.9.3 Baxter Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.9.4 Baxter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.9.5 Baxter Recent Developments
• 12.10 CEPiA Sanofi
  • 12.10.1 CEPiA Sanofi Company Information
  • 12.10.2 CEPiA Sanofi Overview
  • 12.10.3 CEPiA Sanofi Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.10.4 CEPiA Sanofi Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.10.5 CEPiA Sanofi Recent Developments
• 12.11 GSK
  • 12.11.1 GSK Company Information
  • 12.11.2 GSK Overview
  • 12.11.3 GSK Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.11.4 GSK Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.11.5 GSK Recent Developments
• 12.12 Pfizer CentreOne
  • 12.12.1 Pfizer CentreOne Company Information
  • 12.12.2 Pfizer CentreOne Overview
  • 12.12.3 Pfizer CentreOne Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.12.4 Pfizer CentreOne Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.12.5 Pfizer CentreOne Recent Developments
• 12.13 Sandoz
  • 12.13.1 Sandoz Company Information
  • 12.13.2 Sandoz Overview
  • 12.13.3 Sandoz Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.13.4 Sandoz Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.13.5 Sandoz Recent Developments
• 12.14 Vetter
  • 12.14.1 Vetter Company Information
  • 12.14.2 Vetter Overview
  • 12.14.3 Vetter Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.14.4 Vetter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.14.5 Vetter Recent Developments
• 12.15 Wuxi Biologics
  • 12.15.1 Wuxi Biologics Company Information
  • 12.15.2 Wuxi Biologics Overview
  • 12.15.3 Wuxi Biologics Biological API Drug Manufacturing Capacity, Sales, Price, Revenue and Gross Margin (2018-2023)
  • 12.15.4 Wuxi Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
  • 12.15.5 Wuxi Biologics Recent Developments

13 Industry Chain and Sales Channels Analysis

• 13.1 Biological API Drug Manufacturing Industry Chain Analysis
• 13.2 Biological API Drug Manufacturing Key Raw Materials
  • 13.2.1 Key Raw Materials
  • 13.2.2 Raw Materials Key Suppliers
• 13.3 Biological API Drug Manufacturing Production Mode & Process
• 13.4 Biological API Drug Manufacturing Sales and Marketing
  • 13.4.1 Biological API Drug Manufacturing Sales Channels
  • 13.4.2 Biological API Drug Manufacturing Distributors
• 13.5 Biological API Drug Manufacturing Customers

14 Biological API Drug Manufacturing Market Dynamics

• 14.1 Biological API Drug Manufacturing Industry Trends
• 14.2 Biological API Drug Manufacturing Market Drivers
• 14.3 Biological API Drug Manufacturing Market Challenges
• 14.4 Biological API Drug Manufacturing Market Restraints

15 Key Finding in The Global Biological API Drug Manufacturing Study

16 Appendix

• 16.1 Research Methodology
  • 16.1.1 Methodology/Research Approach
  • 16.1.2 Data Source
• 16.2 Author Details
• 16.3 Disclaimer

List of Tables

• Table 1. Global Biological API Drug Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Table 2. Major Manufacturers of In-House manufacturing
• Table 3. Major Manufacturers of Contract manufacturing
• Table 4. Global Biological API Drug Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Table 5. Global Biological API Drug Manufacturing Production by Region: 2018 VS 2022 VS 2029 (K MT)
• Table 6. Global Biological API Drug Manufacturing Production by Region (2018-2023) & (K MT)
• Table 7. Global Biological API Drug Manufacturing Production by Region (2024-2029) & (K MT)
• Table 8. Global Biological API Drug Manufacturing Production Market Share by Region (2018-2023)
• Table 9. Global Biological API Drug Manufacturing Production Market Share by Region (2024-2029)
• Table 10. Global Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 11. Global Biological API Drug Manufacturing Revenue by Region (2018-2023) & (US$ Million)
• Table 12. Global Biological API Drug Manufacturing Revenue by Region (2024-2029) & (US$ Million)
• Table 13. Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2023)
• Table 14. Global Biological API Drug Manufacturing Revenue Market Share by Region (2024-2029)
• Table 15. Global Biological API Drug Manufacturing Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Table 16. Global Biological API Drug Manufacturing Sales by Region (2018-2023) & (K MT)
• Table 17. Global Biological API Drug Manufacturing Sales by Region (2024-2029) & (K MT)
• Table 18. Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2023)
• Table 19. Global Biological API Drug Manufacturing Sales Market Share by Region (2024-2029)
• Table 20. Global Biological API Drug Manufacturing Sales by Manufacturers (2018-2023) & (K MT)
• Table 21. Global Biological API Drug Manufacturing Sales Share by Manufacturers (2018-2023)
• Table 22. Global Biological API Drug Manufacturing Revenue by Manufacturers (2018-2023) & (US$ Million)
• Table 23. Global Biological API Drug Manufacturing Revenue Share by Manufacturers (2018-2023)
• Table 24. Biological API Drug Manufacturing Price by Manufacturers 2018-2023 (USD/MT)
• Table 25. Global Key Players of Biological API Drug Manufacturing, Industry Ranking, 2021 VS 2022 VS 2023
• Table 26. Global Biological API Drug Manufacturing Manufacturers Market Concentration Ratio (CR5 and HHI)
• Table 27. Global Biological API Drug Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Biological API Drug Manufacturing as of 2022)
• Table 28. Global Key Manufacturers of Biological API Drug Manufacturing, Manufacturing Base Distribution and Headquarters
• Table 29. Global Key Manufacturers of Biological API Drug Manufacturing, Product Offered and Application
• Table 30. Global Key Manufacturers of Biological API Drug Manufacturing, Date of Enter into This Industry
• Table 31. Mergers & Acquisitions, Expansion Plans
• Table 32. Global Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 33. Global Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 34. Global Biological API Drug Manufacturing Sales Share by Type (2018-2023)
• Table 35. Global Biological API Drug Manufacturing Sales Share by Type (2024-2029)
• Table 36. Global Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 37. Global Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 38. Global Biological API Drug Manufacturing Revenue Share by Type (2018-2023)
• Table 39. Global Biological API Drug Manufacturing Revenue Share by Type (2024-2029)
• Table 40. Biological API Drug Manufacturing Price by Type (2018-2023) & (USD/MT)
• Table 41. Global Biological API Drug Manufacturing Price Forecast by Type (2024-2029) & (USD/MT)
• Table 42. Global Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 43. Global Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 44. Global Biological API Drug Manufacturing Sales Share by Application (2018-2023)
• Table 45. Global Biological API Drug Manufacturing Sales Share by Application (2024-2029)
• Table 46. Global Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 47. Global Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 48. Global Biological API Drug Manufacturing Revenue Share by Application (2018-2023)
• Table 49. Global Biological API Drug Manufacturing Revenue Share by Application (2024-2029)
• Table 50. Biological API Drug Manufacturing Price by Application (2018-2023) & (USD/MT)
• Table 51. Global Biological API Drug Manufacturing Price Forecast by Application (2024-2029) & (USD/MT)
• Table 52. US & Canada Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 53. US & Canada Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 54. US & Canada Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 55. US & Canada Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 56. US & Canada Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 57. US & Canada Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 58. US & Canada Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 59. US & Canada Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 60. US & Canada Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 61. US & Canada Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
• Table 62. US & Canada Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
• Table 63. US & Canada Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
• Table 64. US & Canada Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
• Table 65. Europe Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 66. Europe Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 67. Europe Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 68. Europe Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 69. Europe Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 70. Europe Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 71. Europe Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 72. Europe Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 73. Europe Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 74. Europe Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
• Table 75. Europe Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
• Table 76. Europe Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
• Table 77. Europe Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
• Table 78. China Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 79. China Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 80. China Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 81. China Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 82. China Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 83. China Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 84. China Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 85. China Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 86. Asia Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 87. Asia Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 88. Asia Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 89. Asia Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 90. Asia Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 91. Asia Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 92. Asia Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 93. Asia Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 94. Asia Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 95. Asia Biological API Drug Manufacturing Revenue by Region (2018-2023) & (US$ Million)
• Table 96. Asia Biological API Drug Manufacturing Revenue by Region (2024-2029) & (US$ Million)
• Table 97. Asia Biological API Drug Manufacturing Sales by Region (2018-2023) & (K MT)
• Table 98. Asia Biological API Drug Manufacturing Sales by Region (2024-2029) & (K MT)
• Table 99. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2018-2023) & (K MT)
• Table 100. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Type (2024-2029) & (K MT)
• Table 101. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2018-2023) & (US$ Million)
• Table 102. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Type (2024-2029) & (US$ Million)
• Table 103. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2018-2023) & (K MT)
• Table 104. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Application (2024-2029) & (K MT)
• Table 105. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2018-2023) & (US$ Million)
• Table 106. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Application (2024-2029) & (US$ Million)
• Table 107. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
• Table 108. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2018-2023) & (US$ Million)
• Table 109. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue by Country (2024-2029) & (US$ Million)
• Table 110. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2018-2023) & (K MT)
• Table 111. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales by Country (2024-2029) & (K MT)
• Table 112. Lonza Company Information
• Table 113. Lonza Description and Major Businesses
• Table 114. Lonza Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 115. Lonza Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 116. Lonza Recent Development
• Table 117. Boehringer Ingelheim BioXcellence Company Information
• Table 118. Boehringer Ingelheim BioXcellence Description and Major Businesses
• Table 119. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 120. Boehringer Ingelheim BioXcellence Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 121. Boehringer Ingelheim BioXcellence Recent Development
• Table 122. Celltrion Company Information
• Table 123. Celltrion Description and Major Businesses
• Table 124. Celltrion Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 125. Celltrion Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 126. Celltrion Recent Development
• Table 127. DSM Company Information
• Table 128. DSM Description and Major Businesses
• Table 129. DSM Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 130. DSM Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 131. DSM Recent Development
• Table 132. Samsung BioLogics Company Information
• Table 133. Samsung BioLogics Description and Major Businesses
• Table 134. Samsung BioLogics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 135. Samsung BioLogics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 136. Samsung BioLogics Recent Development
• Table 137. Fujifilm Diosynth Biotechnologies Company Information
• Table 138. Fujifilm Diosynth Biotechnologies Description and Major Businesses
• Table 139. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 140. Fujifilm Diosynth Biotechnologies Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 141. Fujifilm Diosynth Biotechnologies Recent Development
• Table 142. Cytovance Biologics Company Information
• Table 143. Cytovance Biologics Description and Major Businesses
• Table 144. Cytovance Biologics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 145. Cytovance Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 146. Cytovance Biologics Recent Development
• Table 147. AbbVie Company Information
• Table 148. AbbVie Description and Major Businesses
• Table 149. AbbVie Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 150. AbbVie Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 151. AbbVie Recent Development
• Table 152. Baxter Company Information
• Table 153. Baxter Description and Major Businesses
• Table 154. Baxter Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 155. Baxter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 156. Baxter Recent Development
• Table 157. CEPiA Sanofi Company Information
• Table 158. CEPiA Sanofi Description and Major Businesses
• Table 159. CEPiA Sanofi Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 160. CEPiA Sanofi Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 161. CEPiA Sanofi Recent Development
• Table 162. GSK Company Information
• Table 163. GSK Description and Major Businesses
• Table 164. GSK Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 165. GSK Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 166. GSK Recent Development
• Table 167. Pfizer CentreOne Company Information
• Table 168. Pfizer CentreOne Description and Major Businesses
• Table 169. Pfizer CentreOne Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 170. Pfizer CentreOne Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 171. Pfizer CentreOne Recent Development
• Table 172. Sandoz Company Information
• Table 173. Sandoz Description and Major Businesses
• Table 174. Sandoz Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 175. Sandoz Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 176. Sandoz Recent Development
• Table 177. Vetter Company Information
• Table 178. Vetter Description and Major Businesses
• Table 179. Vetter Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 180. Vetter Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 181. Vetter Recent Development
• Table 182. Wuxi Biologics Company Information
• Table 183. Wuxi Biologics Description and Major Businesses
• Table 184. Wuxi Biologics Biological API Drug Manufacturing Capacity Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2018-2023)
• Table 185. Wuxi Biologics Biological API Drug Manufacturing Product Model Numbers, Pictures, Descriptions and Specifications
• Table 186. Wuxi Biologics Recent Development
• Table 187. Key Raw Materials Lists
• Table 188. Raw Materials Key Suppliers Lists
• Table 189. Biological API Drug Manufacturing Distributors List
• Table 190. Biological API Drug Manufacturing Customers List
• Table 191. Biological API Drug Manufacturing Market Trends
• Table 192. Biological API Drug Manufacturing Market Drivers
• Table 193. Biological API Drug Manufacturing Market Challenges
• Table 194. Biological API Drug Manufacturing Market Restraints
• Table 195. Research Programs/Design for This Report
• Table 196. Key Data Information from Secondary Sources
• Table 197. Key Data Information from Primary Sources

List of Figures

• Figure 1. Biological API Drug Manufacturing Product Picture
• Figure 2. Global Biological API Drug Manufacturing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 3. Global Biological API Drug Manufacturing Market Share by Type in 2022 & 2029
• Figure 4. In-House manufacturing Product Picture
• Figure 5. Contract manufacturing Product Picture
• Figure 6. Global Biological API Drug Manufacturing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
• Figure 7. Global Biological API Drug Manufacturing Market Share by Application in 2022 & 2029
• Figure 8. Monoclonal Antibody (mAb) Therapies
• Figure 9. Vaccines
• Figure 10. Insulin Therapies
• Figure 11. Interferon Therapies
• Figure 12. Other
• Figure 13. Biological API Drug Manufacturing Report Years Considered
• Figure 14. Global Biological API Drug Manufacturing Capacity, Production and Utilization (2018-2029) & (K MT)
• Figure 15. Global Biological API Drug Manufacturing Production Market Share by Region in Percentage: 2022 Versus 2029
• Figure 16. Global Biological API Drug Manufacturing Production Market Share by Region (2018-2029)
• Figure 17. Biological API Drug Manufacturing Production Growth Rate in North America (2018-2029) & (K MT)
• Figure 18. Biological API Drug Manufacturing Production Growth Rate in Europe (2018-2029) & (K MT)
• Figure 19. Biological API Drug Manufacturing Production Growth Rate in China (2018-2029) & (K MT)
• Figure 20. Biological API Drug Manufacturing Production Growth Rate in Japan (2018-2029) & (K MT)
• Figure 21. Global Biological API Drug Manufacturing Revenue, (US$ Million), 2018 VS 2022 VS 2029
• Figure 22. Global Biological API Drug Manufacturing Revenue 2018-2029 (US$ Million)
• Figure 23. Global Biological API Drug Manufacturing Revenue (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
• Figure 24. Global Biological API Drug Manufacturing Revenue Market Share by Region in Percentage: 2022 Versus 2029
• Figure 25. Global Biological API Drug Manufacturing Revenue Market Share by Region (2018-2029)
• Figure 26. Global Biological API Drug Manufacturing Sales 2018-2029 ((K MT)
• Figure 27. Global Biological API Drug Manufacturing Sales (CAGR) by Region: 2018 VS 2022 VS 2029 (K MT)
• Figure 28. Global Biological API Drug Manufacturing Sales Market Share by Region (2018-2029)
• Figure 29. US & Canada Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
• Figure 30. US & Canada Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
• Figure 31. Europe Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
• Figure 32. Europe Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
• Figure 33. China Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
• Figure 34. China Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
• Figure 35. Asia (excluding China) Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
• Figure 36. Asia (excluding China) Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
• Figure 37. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales YoY (2018-2029) & (K MT)
• Figure 38. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue YoY (2018-2029) & (US$ Million)
• Figure 39. The Biological API Drug Manufacturing Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
• Figure 40. The Top 5 and 10 Largest Manufacturers of Biological API Drug Manufacturing in the World: Market Share by Biological API Drug Manufacturing Revenue in 2022
• Figure 41. Global Biological API Drug Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
• Figure 42. Global Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 43. Global Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 44. Global Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 45. Global Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 46. US & Canada Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 47. US & Canada Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 48. US & Canada Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 49. US & Canada Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 50. US & Canada Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
• Figure 51. US & Canada Biological API Drug Manufacturing Sales Share by Country (2018-2029)
• Figure 52. U.S. Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 53. Canada Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 54. Europe Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 55. Europe Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 56. Europe Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 57. Europe Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 58. Europe Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
• Figure 59. Europe Biological API Drug Manufacturing Sales Share by Country (2018-2029)
• Figure 60. Germany Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 61. France Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 62. U.K. Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 63. Italy Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 64. Russia Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 65. China Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 66. China Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 67. China Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 68. China Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 69. Asia Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 70. Asia Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 71. Asia Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 72. Asia Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 73. Asia Biological API Drug Manufacturing Revenue Share by Region (2018-2029)
• Figure 74. Asia Biological API Drug Manufacturing Sales Share by Region (2018-2029)
• Figure 75. Japan Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 76. South Korea Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 77. China Taiwan Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 78. Southeast Asia Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 79. India Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 80. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Market Share by Type (2018-2029)
• Figure 81. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Market Share by Type (2018-2029)
• Figure 82. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Market Share by Application (2018-2029)
• Figure 83. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Market Share by Application (2018-2029)
• Figure 84. Middle East, Africa and Latin America Biological API Drug Manufacturing Revenue Share by Country (2018-2029)
• Figure 85. Middle East, Africa and Latin America Biological API Drug Manufacturing Sales Share by Country (2018-2029)
• Figure 86. Brazil Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 87. Mexico Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 88. Turkey Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 89. Israel Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 90. GCC Countries Biological API Drug Manufacturing Revenue (2018-2029) & (US$ Million)
• Figure 91. Biological API Drug Manufacturing Value Chain
• Figure 92. Biological API Drug Manufacturing Production Process
• Figure 93. Channels of Distribution
• Figure 94. Distributors Profiles
• Figure 95. Bottom-up and Top-down Approaches for This Report
• Figure 96. Data Triangulation
• Figure 97. Key Executives Interviewed